Advertisement

Topics

Saphetor Precision Medicine Platform Now Serving Aurigen Patients to Enhance Discovery of Personalized Cancer Therapies

02:00 EDT 12 Jul 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Saphetor SA, a Swiss precision-medicine company fully dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a wide-ranging, pay-per-use service agreement with Aurigen SA. Aurige...

Other Sources for this Article

Saphetor SA
Andreas Massouras, PhD, +41 21 552 09 77
andreas.massouras@saphetor.com
Chief Executive Officer

NEXT ARTICLE

More From BioPortfolio on "Saphetor Precision Medicine Platform Now Serving Aurigen Patients to Enhance Discovery of Personalized Cancer Therapies"

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...